Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ACMI - Accumed Inc. -- Ignore unavailable to you. Want to Upgrade?

To: Frank Buck who wrote (1330)	1/30/1998 10:32:00 PM
From: Cisco	Read Replies (2) \| Respond to of 1894

®Cisco will have a new cast member for ACT II of the Mystery Web Theater.¯ Frank, I have been watching DIGE for a few months but I am not ready to add it to the Mystery Web Theater for 1998 yet! There are two other companies you may want to take a look at!! I believe Sigmund will find this first one very interesting. It takes direct aim at ThinPrep! This company may be a great potential strategic partner for AccuMed! It announced its new product on November 10, 1997. monogen.com The second company is slated to begin clinical trials in the first quarter of 1998 leading to regulatory approval and product launch in Spring 1999. I will let you guess who this company is taking direct aim at! morphometrix.com I believe that readers of this thread are beginning to understand now why the creation of OncoMedics was so important. This is just another reason: In today's rapidly-moving, technology-driven healthcare marketplace, the need to bring new products to the marketplace as quickly as possible is paramount. We believe this to be true from the point of view of improved patient outcome as well as business profitability. The equity carve-out provides an entity in which strategic partners can join with AccuMed, through contribution of technology and financial resources, to introduce a more diverse offering of high quality products to the market in a much shorter timeframe. (Peter Gombrich, Chairman and CEO of AccuMed International) Cisco